rawfin.tv
STERIS Appoints bioMérieux CEO Pierre Boulud to Board
MarketsstocksAI Generated

STERIS Appoints bioMérieux CEO Pierre Boulud to Board

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

STERIS announced the retirement of director Richard C. Breeden in 2026 after 18 years on the board. Concurrently, the company expanded its board, appointing bioMérieux CEO Pierre Boulud as a new director.

STECorporate GovernanceBoard AppointmentHealthcare

Related Articles

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks
Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks
Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

stocks
Barclays Workforce Trimmed 5% as Bank Increases Focus on AI

Barclays Workforce Trimmed 5% as Bank Increases Focus on AI

stocks